NEW: ECHAMP report – ‘The Availability of Homeopathic and Anthroposophic Medicinal Products in the EU’
27 Nov 2013
A new report has been published by ECHAMP providing an up-to-date and objective analysis of the status and deficits of availability of homeopathic and anthroposophic medicinal products in the EU.
This is the first such comprehensive report, with recent information on the demand for and availability of these products, and on their regulatory status. It has been prepared in cooperation with PricewaterhouseCoopers (PwC). It draws on a variety of sources: pan-European socio-economic, sales and demand data relating to health care provision; regulatory data from referenced publications, the websites of the medicines agencies, and the findings of a first independent survey by PwC (27 national medicines agencies); and the findings of a second independent survey by PwC, which tests the reality of the availability in a quantitative and a qualitative way at the point of delivery of medicinal products to the citizens.
The report was launched on 26 November at a lunch reception in the European Parliament, hosted by Dr Thomas Ulmer MEP. Further details of the report and the event will be included in the December issue of ECHAMP e-News, due out next week.
The launch of the report was accompanied by the publication of a new brochure from ECHAMP: ‘Homeopathic and Anthroposophic Medicinal Products - A thriving European tradition.’ This new brochure provides an introduction to homeopathic and anthroposophic medicinal products and their role in European health care.
From today, you can download from the ECHAMP website:
- the report summary and the full report: ‘The Availability of Homeopathic and Anthroposophic Medicinal Products in the EU’
- the launch presentation: The Availability of Homeopathic and Anthroposophic Medicinal Products in the EU - Towards suitable regulation
- the new brochure: ‘Homeopathic and Anthroposophic Medicinal Products - A thriving European tradition’